Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating adults with
newly diagnosed primary malignant glioblastoma multiforme.